We are live on
!
Find out more
S
swisspartners Portfolio holdings
AUM
$78.4M
1-Year Est. Return
9.82%
This Fund
S&P 500
This Quarter
Est. Return
-18.17%
1 Year Est. Return
-9.82%
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$105M
AUM Growth
-$21.8M
(-17%)
Cap. Flow
-$692K
Cap. Flow
% of AUM
-0.66%
Top 10 Holdings %
Top 10 Hldgs %
51.44%
Holding
88
New
7
Increased
14
Reduced
11
Closed
10
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
Berkshire Hathaway Class A
BRK.A
|
+$2.36M |
| 2 |
Ralph Lauren
RL
|
+$1.21M |
| 3 |
Alaska Air
ALK
|
+$1.17M |
| 4 |
Marathon Petroleum
MPC
|
+$841K |
| 5 |
Sibanye-Stillwater
SBSW
|
+$314K |
Top Sells
| Rank | Stock | Value |
|---|---|---|
| 1 |
Bristol-Myers Squibb
BMY
|
+$2.45M |
| 2 |
Petrobras
PBR
|
+$2.17M |
| 3 |
TSMC
TSM
|
+$1.26M |
| 4 |
PLL
Piedmont Lithium
PLL
|
+$730K |
| 5 |
Netflix
NFLX
|
+$273K |
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Technology | 22.58% |
| 2 | Consumer Discretionary | 18.85% |
| 3 | Financials | 18.69% |
| 4 | Communication Services | 8.3% |
| 5 | Industrials | 8.23% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | |
|---|---|---|---|---|---|---|
|
HURA
76
TuHURA Biosciences
HURA
$143M
| $79K | 0.08% |
157
| – | – |
|
77
cbdMD
YCBD
$5.98M
| $52K | 0.05% |
321
| – | – |
|
|
LYLT
78
DELISTED
Loyalty Ventures Inc. Common Stock
LYLT
| $44K | 0.04% |
11,940
| – | – |
|
79
AbbVie
ABBV
$450B
| – | – |
-1,290
| Closed | -$209K |
|
|
ANSS
80
DELISTED
Ansys
ANSS
| – | – |
-795
| Closed | -$252K |
|
|
81
Bristol-Myers Squibb
BMY
$124B
| – | – |
-33,500
| Closed | -$2.45M |
|
82
CVS Health
CVS
$137B
| – | – |
-2,065
| Closed | -$209K |
|
83
Idexx Laboratories
IDXX
$44.8B
| – | – |
-450
| Closed | -$246K |
|
84
Lowe's Companies
LOW
$117B
| – | – |
-1,000
| Closed | -$202K |
|
|
85
Netflix
NFLX
$290B
| – | – |
-7,290
| Closed | -$273K |
|
|
86
Petrobras
PBR
$116B
| – | – |
-146,300
| Closed | -$2.17M |
|
|
PLL
87
DELISTED
Piedmont Lithium
PLL
| – | – |
-10,000
| Closed | -$730K |
|
|
88
TSMC
TSM
$2.07T
| – | – |
-12,070
| Closed | -$1.26M |
|
Similar funds
PAM
CFS
CLCM
SGMPI
BO
BC
LCH
SCFS
swisspartners's Q2 2022 Portfolio in Review
As of Q2 2022, swisspartners held 88 positions worth $105M, down 17% from $126M the previous quarter. Its ten largest holdings account for 51% of the portfolio.
swisspartners's Q2 2022 filing shows 7 new, 14 increased, 11 reduced and 10 closed positions. Its largest new stake was Ralph Lauren: 12,000 shares worth $1.11M. The largest sale was Bristol-Myers Squibb, an estimated $2.45M.
By sector, the portfolio is most concentrated in Technology at 23% of assets, down from 23% a quarter earlier, followed by Consumer Discretionary and Financials.
- swisspartners's largest Q2 2022 buy was Ralph Lauren: 12,000 shares worth $1.11M.
- swisspartners added most to Berkshire Hathaway Class A in Q2 2022, an estimated $2.36M increase.
- swisspartners's biggest Q2 2022 reduction was Moderna, cutting an estimated $250K.
- swisspartners fully exited Bristol-Myers Squibb in Q2 2022, selling an estimated $2.45M.
- swisspartners's ten largest holdings make up 51% of its $105M portfolio in Q2 2022.
- swisspartners opened 7 new positions and closed 10 in Q2 2022.
- swisspartners's portfolio value fell 17% quarter-over-quarter to $105M.
Based on swisspartners's 13F filing for Q2 2022, filed 10 Aug 2022.